Clarity Act’s Markup Progress Depends on Dems in Senate
A key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
Explore how weekly and monthly automatic buys work for Dividend Aristocrats ETFs and why they can simplify investing. Learn practical steps to set up automatic contributions.
16,919 articlesA key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Cardano is sparking renewed trader interest as ADA price predictions point to a potential rally. Analysts cite chart ...
A Brazilian fund made a sizable bet on MercadoLibre even as the stock slid over the past year. This article unpacks t...
Live events are back, but investors want proof StubHub can grow profits. This guide breaks down the stubhub (stub) 20...
As investors digest Karyopharm's Q1 2026 earnings, this guide breaks down what to watch, how to interpret the numbers...
A Latin American e-commerce and fintech stock posts 27 consecutive quarters of 30%+ revenue growth, defying geopoliti...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A viral episode claimed an AI-generated Monet fooled millions, but the artwork was genuine. The episode underscores h...
ATRenew (RERE) 2026 earnings in Q1 offer a clearer view of the company’s path forward. This guide breaks down what to...
Unlock the essentials of the earn 2025 earnings transcript. This plain‑speak guide breaks down what to listen for, ho...